TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Hospira, Inc. (NYSE:HSP) Investor Files Lawsuit Over Alleged Wrongdoing In Proposed Acquisition By Pfizer

  • If you purchased shares of Hospira, Inc. (NYSE:HSP) and currently hold any of those NYSE:HSP shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Company
Hospira, Inc.
Security
NYSE: HSP

Case Name
Hospira Deal Case 02/09/2015
Type of Lawsuit
Mergers and Acquisition
You must register or login to receive notifications.

Click here to subscribe to Hospira, Inc..
Summary

February 13, 2015 (Shareholders Foundation) - An investor, who currently holds shares of Hospira, Inc. (NYSE:HSP), filed a lawsuit in effort to halt the proposed takeover of Hospira, Inc. by Pfizer Inc.
The plaintiff alleges that the defendants breached their fiduciary duties owed to NYSE:HSP stockholders by agreeing to sell Hospira, Inc. too cheaply via an unfair process to Pfizer Inc.

On February 5, 2015, Pfizer Inc. (NYSE: PFE) and Hospira, Inc. (NYSE: HSP) announced that they have entered into a merger agreement under which Pfizer will acquire Hospira for $90 a share in cash for a total enterprise value of approximately $17 billion.

However, the plaintiff claims that the $90-offer is too low and undervalues Hospira, Inc. In addition, the plaintiff claims that the process is also unfair to NYSE:HSP stockholders